Health & ScienceAI-Designed Antibody BD200 Outperforms Standard Treatments in Drug-Resistant Cancers, Marking First Clinical Trial for Machine Learning PlatformSalvado•Apr 18, 2026
HealthcareBiotech Funding Drought Puts $300M Ophthalmology Drug at Risk of Capital CollapseViaNews Editorial Team•Mar 1, 2026
AnalysisFour Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research CycleViaNews Editorial Team•Feb 15, 2026
